Emergent Biosolutions Stock Investor Sentiment

EBS Stock  USD 9.85  0.37  3.90%   
Slightly above 56% of all Emergent Biosolutions' private investors are looking to take a long position. The analysis of the overall investor sentiment regarding Emergent Biosolutions suggests that some traders are interested. Emergent Biosolutions' investing sentiment can be driven by a variety of factors including economic data, Emergent Biosolutions' earnings reports, geopolitical events, and overall market trends.
  
over three months ago at www.macroaxis.com         
Disposition of 1167 shares by William Hartzel of Emergent Biosolutions at 6.19 subject to Rule 16b-3
Macroaxis News
over three months ago at finance.yahoo.com         
Emergent BioSolutions Continues Driving Progress Against the Opioid Epidemic Recognizes National Nal...
Yahoo News
over three months ago at globenewswire.com         
Emergent BioSolutions Continues Driving Progress Against the Opioid Epidemic Recognizes National Nal...
Macroaxis News: globenewswire.com
over three months ago at finance.yahoo.com         
Myriad Down 5.2 percent Since Last Earnings Report Can It Rebound?
Yahoo News
over three months ago at benzinga.com         
Emergent BioSolutions Continues Driving Progress Against the Opioid Epidemic Recognizes National Nal...
benzinga news
over three months ago at investing.com         
Emergent BioSolutions director sells 61,100 in company stock
Investing News at Macroaxis
over three months ago at www.macroaxis.com         
Disposition of 10000 shares by Kathryn Zoon of Emergent Biosolutions at 6.11 subject to Rule 16b-3
Macroaxis News
over three months ago at investing.com         
Emergent BioSolutions director sells 8,436 in company stock
Investing News at Macroaxis
over six months ago at www.macroaxis.com         
Disposition of 1830 shares by Kathryn Zoon of Emergent Biosolutions at 4.61 subject to Rule 16b-3
Macroaxis News
over six months ago at www.macroaxis.com         
Acquisition by Zsolt Harsanyi of 25748 shares of Emergent Biosolutions at 5.02 subject to Rule 16b-3
Macroaxis News
over six months ago at investing.com         
Acquisition by Ronald Richard of 25748 shares of Emergent Biosolutions at 5.02 subject to Rule 16b-3
Investing News at Macroaxis
over six months ago at bizjournals.com         
Heres how many local Emergent BioSolutions employees are being laid off
bizjournals News
over six months ago at investing.com         
Emergent BioSolutions director sells over 6,000 in company stock
Investing News at Macroaxis
over six months ago at investorplace.com         
7 Stocks to Buy Immediately Following Strong Earnings
sbwire news
over six months ago at investorplace.com         
Disposition of 1089 shares by Kathryn Zoon of Emergent Biosolutions at 5.78 subject to Rule 16b-3
sbwire news
Far too much social signal, news, headlines, and media speculation about Emergent Biosolutions that are available to investors today. That information is available publicly through Emergent media outlets and privately through word of mouth or via Emergent internal channels. However, regardless of the origin, that massive amount of Emergent data is challenging to quantify into actionable patterns, especially for investors that are not very sophisticated with ever-evolving tools and techniques used in the investment management field.
A primary focus of Emergent Biosolutions news analysis is to determine if its current price reflects all relevant headlines and social signals impacting the current market conditions. A news analyst typically looks at the history of Emergent Biosolutions relative headlines and hype rather than examining external drivers such as technical or fundamental data. It is believed that price action tends to repeat itself due to investors' collective, patterned thinking related to Emergent Biosolutions' headlines and news coverage data. This data is often completely overlooked or insufficiently analyzed for actionable insights to drive Emergent Biosolutions alpha.

Emergent Biosolutions Performance against Dow Jones

 Price Growth (%)  
       Timeline  

Additional Tools for Emergent Stock Analysis

When running Emergent Biosolutions' price analysis, check to measure Emergent Biosolutions' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Emergent Biosolutions is operating at the current time. Most of Emergent Biosolutions' value examination focuses on studying past and present price action to predict the probability of Emergent Biosolutions' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Emergent Biosolutions' price. Additionally, you may evaluate how the addition of Emergent Biosolutions to your portfolios can decrease your overall portfolio volatility.